Cambiar Investors’s Integra LifeSciences IART Stock Holding History

Cambiar Investors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-805,104	Closed	-$24M	–	159
2015 Q3	$24M	Sell	805,104 -319,466	-28%	-$9.99M	0.35%	107
2015 Q2	$31M	Sell	1,124,570 -202,685	-15%	-$5.4M	0.43%	102
2015 Q1	$33.4M	Sell	1,327,255 -123,677	-9%	-$2.92M	0.49%	93
2014 Q4	$32.2M	Sell	1,450,932 -270,225	-16%	-$5.48M	0.49%	95
2014 Q3	$34.9M	Sell	1,721,157 -13,186	-0.8%	-$262K	0.5%	94
2014 Q2	$33.4M	Buy	1,734,343 +64,212	+4%	+$1.2M	0.47%	92
2014 Q1	$31.4M	Sell	1,670,131 -63,537	-4%	-$1.23M	0.46%	93
2013 Q4	$33.8M	Sell	1,733,668 -72,653	-4%	-$1.33M	0.5%	82
2013 Q3	$29.7M	Sell	1,806,321 -205,697	-10%	-$3.3M	0.49%	82
2013 Q2	$30.1M	Buy	+2,012,018	New	+$29.5M	0.49%	85

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Cambiar Investors's IART Position: Q4 2015 in Review

Cambiar Investors sold out of Integra LifeSciences (IART) in Q4 2015, closing a stake of 805,104 shares — an estimated $24M sold.

Cambiar Investors first reported a position in IART in Q2 2013 and held it in 10 quarters. The position peaked at $34.9M in Q3 2014. 186 funds tracked by Wall St. Rank hold IART as of Q4 2015.

Cambiar Investors reported no remaining Integra LifeSciences position as of Q4 2015 after selling out during the quarter.
Cambiar Investors sold 805,104 Integra LifeSciences shares in Q4 2015, an estimated $24M.
Cambiar Investors first reported a position in Integra LifeSciences in Q2 2013 and held it in 10 quarters.
Cambiar Investors's Integra LifeSciences position peaked at $34.9M in Q3 2014.
186 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2015.

Based on Cambiar Investors's 13F filing for Q4 2015, filed 27 Jan 2016.